Finance

Lists
Why is 4572 down 8,80%?
Dive Deeper
4572:TYO
Carna Biosciences, Inc.
373,00 JP¥
-8,80%
(-36,00) 1D
6 հոկ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4572...
Open
377 JP¥
High
379 JP¥
Low
373 JP¥
Mkt. cap
7,95 մլրդ
Avg. vol.
126,65 հզր
Volume
95,90 հզր
52-wk high
512 JP¥
52-wk low
200 JP¥
EPS
-111 JP¥
Shares outstanding
10,14 մլն
No. of employees
61
Open
377 JP¥
High
379 JP¥
Low
373 JP¥
Mkt. cap
7,95 մլրդ
Avg. vol.
126,65 հզր
Volume
95,90 հզր
52-wk high
512 JP¥
52-wk low
200 JP¥
EPS
-111 JP¥
Shares outstanding
10,14 մլն
No. of employees
61
News stories
From web sources and news partners
About Carna Biosciences, Inc.
CEO-
Employees61
Founded10 ապր, 2003 թ.
Headquarters-
Sector-
Websitecarnabio.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
144,33 մլն
183,57 մլն
183,64 մլն
217,36 մլն
Cost of goods sold
47,38 մլն
66,26 մլն
52,35 մլն
56,65 մլն
Cost of revenue
47,38 մլն
66,26 մլն
52,35 մլն
56,65 մլն
Research and development expenses
-
1,85 մլրդ
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
595,96 մլն
-1,21 մլրդ
589,72 մլն
656,28 մլն
Operating expense
595,96 մլն
640,46 մլն
589,72 մլն
656,28 մլն
Total operating expenses
643,35 մլն
706,72 մլն
642,07 մլն
712,93 մլն
Operating income
-499,01 մլն
-523,14 մլն
-458,44 մլն
-495,56 մլն
Other non operating income
-39,00 հզր
-770,00 հզր
369,00 հզր
-11,37 մլն
EBT including unusual items
-543,38 մլն
-571,28 մլն
-512,11 մլն
-525,89 մլն
EBT excluding unusual items
-535,04 մլն
-555,94 մլն
-488,97 մլն
-517,03 մլն
Income tax expense
572,00 հզր
-287,00 հզր
1,12 մլն
-122,00 հզր
Effective tax rate
-0,11%
0,05%
-0,22%
0,02%
Other operating expenses
-
-
-
-
Net income
-543,95 մլն
-570,99 մլն
-513,24 մլն
-525,76 մլն
Net profit margin
-376,88%
-311,05%
-279,49%
-241,88%
Earnings per share
-
-
-
-
Interest and investment income
993,00 հզր
-
932,00 հզր
1,07 մլն
Interest expense
-33,90 մլն
-17,72 մլն
-13,19 մլն
-20,81 մլն
Net interest expenses
-32,91 մլն
-17,72 մլն
-12,25 մլն
-19,75 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-491,20 մլն
-515,40 մլն
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps